Henghui Zhang

35 North Garden Rd
Haidian, 100089, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 31 publications

Single-cell dissection of persistent tumor antigens in non-responders reveals opportunities for TAA-targeted vaccination after neoadjuvant therapy in esophageal squamous cell carcinoma.

Single-cell dissection of persistent tumor antigens in non-responders reveals opportunities for TAA-targeted vaccination after neoadjuvant therapy in esophageal squamous cell carcinoma.

Journal: Journal for immunotherapy of cancer
Published: April 01, 2026

Development of a multi-epitope mRNA vaccine targeting tumor-associated antigens for esophageal squamous cell carcinoma.

Development of a multi-epitope mRNA vaccine targeting tumor-associated antigens for esophageal squamous cell carcinoma.

Journal: NPJ vaccines
Published: June 27, 2025

Diverse approaches and sources to derive antitumor T cell for liver cancer: a single-cell sequence based research.

Diverse approaches and sources to derive antitumor T cell for liver cancer: a single-cell sequence based research.

Journal: Hepatology international
Published: November 16, 2024

Prognostic and predictive value of angiogenesis-associated serum proteins for immunotherapy in esophageal cancer.

Prognostic and predictive value of angiogenesis-associated serum proteins for immunotherapy in esophageal cancer.

Journal: Journal for immunotherapy of cancer
Published: January 08, 2024

Clinical efficacy and identification of factors confer resistance to afatinib (tyrosine kinase inhibitor) in EGFR-overexpressing esophageal squamous cell carcinoma.

Clinical efficacy and identification of factors confer resistance to afatinib (tyrosine kinase inhibitor) in EGFR-overexpressing esophageal squamous cell carcinoma.

Journal: Signal transduction and targeted therapy
Published: November 22, 2023

Germline HLA-B evolutionary divergence influences the efficacy of immune checkpoint blockade therapy in gastrointestinal cancer.

Germline HLA-B evolutionary divergence influences the efficacy of immune checkpoint blockade therapy in gastrointestinal cancer.

Journal: Genome medicine
Published: March 08, 2021

Single cell transcriptome revealed tumor associated antigen (TAA) profile in lung adenocarcinoma (LUAD).

Single cell transcriptome revealed tumor associated antigen (TAA) profile in lung adenocarcinoma (LUAD).

Journal: Biomarker research
Published: February 22, 2021

Genomic features and tumor immune microenvironment alteration in NSCLC treated with neoadjuvant PD-1 blockade.

Genomic features and tumor immune microenvironment alteration in NSCLC treated with neoadjuvant PD-1 blockade.

Journal: NPJ precision oncology
Published: February 11, 2021

A Machine Learning Approach Yields a Multiparameter Prognostic Marker in Liver Cancer.

A Machine Learning Approach Yields a Multiparameter Prognostic Marker in Liver Cancer.

Journal: Cancer immunology research
Published: July 23, 2020

Prediction of immune checkpoint inhibition with immune oncology-related gene expression in gastrointestinal cancer using a machine learning classifier.

Prediction of immune checkpoint inhibition with immune oncology-related gene expression in gastrointestinal cancer using a machine learning classifier.

Journal: Journal for immunotherapy of cancer
Published: July 22, 2020

Identification of immune checkpoint and cytokine signatures associated with the response to immune checkpoint blockade in gastrointestinal cancers.

Identification of immune checkpoint and cytokine signatures associated with the response to immune checkpoint blockade in gastrointestinal cancers.

Journal: Cancer immunology, immunotherapy : CII
Published: July 19, 2020

Storm of soluble immune checkpoints associated with disease severity of COVID-19.

Storm of soluble immune checkpoints associated with disease severity of COVID-19.

Journal: Signal transduction and targeted therapy
Published: July 09, 2020
Showing 1-12 of 31

Last Updated: 09/26/2026